Enhancement of in vitro therapeutic efficacy using combination paclitaxel and ceramide therapy using EGFR targeted biodegradable polymeric nanoparticles in ovarian cancer model

Enhancement of in vitro therapeutic efficacy using combination paclitaxel and ceramide therapy using EGFR targeted biodegradable polymeric nanoparticles in ovarian cancer model

Currently, tumor-cell resistance to the chemotherapy is key reason for failure of the clinical treatment of cancer cells; almost all chemotherapeutic strategies used are susceptible to multidrug resistance (MDR). The development of MDR is major hindrance to eradication of cancer as it interferes wit...

Full description

Bibliographic Details
Published:
Online Access:http://hdl.handle.net/2047/d20002956
id ndltd-NEU--neu-1777
record_format oai_dc
spelling ndltd-NEU--neu-17772021-05-25T05:10:13ZEnhancement of in vitro therapeutic efficacy using combination paclitaxel and ceramide therapy using EGFR targeted biodegradable polymeric nanoparticles in ovarian cancer modelCurrently, tumor-cell resistance to the chemotherapy is key reason for failure of the clinical treatment of cancer cells; almost all chemotherapeutic strategies used are susceptible to multidrug resistance (MDR). The development of MDR is major hindrance to eradication of cancer as it interferes with the effect of therapeutic agents on tumors and increases chances of cancer resurgence.http://hdl.handle.net/2047/d20002956
collection NDLTD
sources NDLTD
description Currently, tumor-cell resistance to the chemotherapy is key reason for failure of the clinical treatment of cancer cells; almost all chemotherapeutic strategies used are susceptible to multidrug resistance (MDR). The development of MDR is major hindrance to eradication of cancer as it interferes with the effect of therapeutic agents on tumors and increases chances of cancer resurgence.
title Enhancement of in vitro therapeutic efficacy using combination paclitaxel and ceramide therapy using EGFR targeted biodegradable polymeric nanoparticles in ovarian cancer model
spellingShingle Enhancement of in vitro therapeutic efficacy using combination paclitaxel and ceramide therapy using EGFR targeted biodegradable polymeric nanoparticles in ovarian cancer model
title_short Enhancement of in vitro therapeutic efficacy using combination paclitaxel and ceramide therapy using EGFR targeted biodegradable polymeric nanoparticles in ovarian cancer model
title_full Enhancement of in vitro therapeutic efficacy using combination paclitaxel and ceramide therapy using EGFR targeted biodegradable polymeric nanoparticles in ovarian cancer model
title_fullStr Enhancement of in vitro therapeutic efficacy using combination paclitaxel and ceramide therapy using EGFR targeted biodegradable polymeric nanoparticles in ovarian cancer model
title_full_unstemmed Enhancement of in vitro therapeutic efficacy using combination paclitaxel and ceramide therapy using EGFR targeted biodegradable polymeric nanoparticles in ovarian cancer model
title_sort enhancement of in vitro therapeutic efficacy using combination paclitaxel and ceramide therapy using egfr targeted biodegradable polymeric nanoparticles in ovarian cancer model
publishDate
url http://hdl.handle.net/2047/d20002956
_version_ 1719406076459220992

Similar Items